{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:42Z","timestamp":1791264102651,"version":"4.1.0"},"reference-count":28,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3201\/eid2203.151430","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T13:54:36Z","timestamp":1453902876000},"source":"Crossref","is-referenced-by-count":37,"title":["Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis"],"prefix":"10.3201","volume":"22","author":[{"given":"Jennifer","family":"Furin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grania","family":"Brigden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Lessem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharonann","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2203.151430-201602181200-R1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1473-3099(14)70028-3","article-title":"Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers and vaccines.","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R2","unstructured":"Walsh J. Review on antimicrobial resistance: tackling drug-resistant infections. February 2015 [cited 2015 Dec 29]. http:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf"},{"key":"key-10.3201\/eid2203.151430-201602181200-R3","doi-asserted-by":"publisher","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2203.151430-201602181200-R4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1753465812452193","article-title":"New treatment options for multidrug-resistant tuberculosis.","volume":"6","author":"Field","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis.","volume":"360","author":"Diacon","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2203.151430-201602181200-R6","unstructured":"US Food and Drug Administration. FDA approval letter for Sirturo (bedaquiline). 2012 [cited 2015 Dec 29]. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist"},{"key":"key-10.3201\/eid2203.151430-201602181200-R7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline.","volume":"371","author":"Diacon","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2203.151430-201602181200-R8","unstructured":"World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Geneva: The Organization; 2013."},{"key":"key-10.3201\/eid2203.151430-201602181200-R9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis.","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2203.151430-201602181200-R10","unstructured":"Business Wire. Otsuka wins European marketing authorization for Deltyba\u2122 (delamanid) [cited 2015 Aug 25]. http:\/\/www.businesswire.com\/news\/home\/20140429006457\/en\/Otsuka-Wins-European-Marketing-Authorization-Deltyba"},{"key":"key-10.3201\/eid2203.151430-201602181200-R11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1183\/09031936.00125812","article-title":"Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.","volume":"41","author":"Skripconoka","year":"2013","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2203.151430-201602181200-R12","unstructured":"World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance. Geneva: The Organization; 2014."},{"key":"key-10.3201\/eid2203.151430-201602181200-R13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijid.2014.12.012","article-title":"Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.","volume":"32","author":"Lessem","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R14","doi-asserted-by":"publisher","first-page":"e0119332","DOI":"10.1371\/journal.pone.0119332","article-title":"Mortality among MMDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors.","volume":"10","author":"Chung-Delgado","year":"2015","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2203.151430-201602181200-R15","unstructured":"Manda SO, Masenyetse LJ, Lancaster JL, van der Walt ML. Risk of death among HIV co-infected multidrug-resistant tuberculosis patients, compared to morality in the general population of South Africa. J AIDS Clin Res. 2013;(Jul 2)Suppl 3:7."},{"key":"key-10.3201\/eid2203.151430-201602181200-R16","unstructured":"M\u00e9decins Sans Fronti\u00e8res Access Campaign. Call to action: accelerate access to DR-TB drugs [cited 2015 Aug 25]. http:\/\/www.msfaccess.org\/content\/call-action-accelerate-access-dr-tb-drugs"},{"key":"key-10.3201\/eid2203.151430-201602181200-R17","unstructured":"Global Laboratory Initiative\/Global Drug-Resistance Initiative. Joint Partners Forum for strengthening and aligning TB diagnosis and treatment. Geneva, Switzerland. April 27\u201330, 2015 [cited 2015 Aug 25]. http:\/\/www.stoptb.org\/wg\/mdrtb\/"},{"key":"key-10.3201\/eid2203.151430-201602181200-R18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5588\/ijtld.12.0017","article-title":"Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis.","volume":"17","author":"Horsburgh","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","article-title":"Content analysis and thematic analysis: implications for conducting a qualitative descriptive study.","volume":"15","author":"Vaismoradi","year":"2013","journal-title":"Nurs Health Sci"},{"key":"key-10.3201\/eid2203.151430-201602181200-R20","unstructured":"World Health Organization. Companion handbook to the 2011 WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: The Organization; 2014."},{"key":"key-10.3201\/eid2203.151430-201602181200-R21","unstructured":"World Health Organization. Global tuberculosis report 2014. Geneva: The Organization; 2014."},{"key":"key-10.3201\/eid2203.151430-201602181200-R22","unstructured":"World Health Organization. Introduction of bedaquiline for the treatment of multidrug-resistant tuberculosis at country level\u2014implementation plan. WHO\/HTM\/TB\/2015 [cited 2015 Aug 25]. http:\/\/www.who.int\/tb\/publications\/WHO_BDQimplementationplan.pdf"},{"key":"key-10.3201\/eid2203.151430-201602181200-R23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5588\/ijtld.14.0944","article-title":"Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.","volume":"19","author":"Ndjeka","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R24","unstructured":"Otsuka Holdings Co. Ltd. Otuska: people creating new products for better health worldwide [cited 2015 Oct 14]. http:\/\/www.otsuka.com\/en\/"},{"key":"key-10.3201\/eid2203.151430-201602181200-R25","unstructured":"Stop TB. Partnership. USAID bedaquiline donation program begins today [cited 2015 Aug 25]. http:\/\/www.stoptb.org\/news\/stories\/2015\/ns15_015.asp"},{"key":"key-10.3201\/eid2203.151430-201602181200-R26","unstructured":"Wells CD. Delamanid for MDR\u2010TB: current development progress and ongoing access plans [cited 2015 Aug 25]. http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/M7\/3.%20WELLS_Introduction%20to%20Delamanid.pdf"},{"key":"key-10.3201\/eid2203.151430-201602181200-R27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5588\/ijtld.12.0537","article-title":"Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.","volume":"17","author":"Toczek","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2203.151430-201602181200-R28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2471\/BLT.13.122028","article-title":"Principles for designing future regimens for multidrug-resistant tuberculosis.","volume":"92","author":"Brigden","year":"2014","journal-title":"Bull World Health Organ"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/3\/15-1430_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:25:12Z","timestamp":1732922712000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/3\/15-1430_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2203.151430","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}